Effects of quinolones, magnesium deficiency or zinc deficiency on joint cartilage in rats

Magnesium - Bulletin

Volumn 19, Issue 1, 1997, Pages 7-22

  Stahlmann, R ^a,d   Vormann, J ^b   Gunther T ^b   Forster C ^a   Zippel, U ^a   Lozo, E ^a   Schwabe, R ^a   Kociok, K ^a   Shakibaei, M ^c   Merker, H J ^c  

^a Institut fur Klinische Pharmakologie und Toxikologie   (Germany)

^b Institut fuer Biochemie und Molekularbiologie   (Germany)

^c Institute of Veterinary Anatomy   (Germany)

^d Institut fur Pharmakologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 21744451443     PISSN: 0172908X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Bendele, A. M.; Hulman, J. F.; Harvey, A. K.; Hrubey, P. S.; Chandrasekhar, S.: Passive role of articular chondrocytes in quinolone-induced arthropathy in guinea pigs. Toxicol. Pathol. 18 (1990) 304-312.
2. Bethell, D. B.; Day, N. P. J.; Dung, N. M.; McMullin, C.; Loan, H. T.; Tam, D. T. H.; Minh, L. T. N.; Linh, N. T. M.; Dung, N. Q.; Vinh, H.; MacGowan, A. P.; White, L. O.; White, N. J.: Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever. Antimicrob. Agents Chemother. 40 (1996) 2167-2172.
3. Borner, K.; Hartwig, H.; Lode, H.; Höffken, G.: Chromatographische Bestimmung von Ofloxacin in Körperflüssigkeiten, Fresenius Z. Analyt. Chemie 324 (1986) 355.
4. Burkhardt, J.; Hill, M. A.; Carlton, W. W.; Kesterson, J. W.: Histologic and histochemical changes in articular cartilages of immature Beagle dogs dosed with difloxacin, a fluoroquinolone. Vet. Pathol. 27 (1990) 162-170.
5. Burkhardt; J. E.; Hill, M. A.; Turek, J. J.; Carlton, W. W.: Ultrastructural changes in articular cartilage of immature Beagle dogs dosed with difloxacin, a fluoroquinolone. Vet. Pathol. 29 (1992) 230-238.
6. Butler, L. D.; Biehl, M. L.; Beierschmitt, W. P.; Beutler, N. J.; Parzych, B. M.; Coleman, G. L.: Preclinical systemic toxicity studies of CP 74,667, a quinolone antimicrobial agent. Toxicologist 13 (1993) 376 (abstract 1471).
7. Chapman, J. S.; Georgopapadakou, N. H.: Routes of quinolone permeation in Escherichia coli. Antimicrob. Agents Chemother. 32 (1988) 438-442.
8. Christ, W.; Esch, B.: Adverse reactions to fluoroquinolones in adults and children. Inf. Dis. Clin. Pract. 3 (Suppl 3) (1994) S. 168-176.
9. Classen, U. G.; Seitz, G.; Grimm, P.; Classen, H. G.: Influence of high and low dietary magnesium levels on functional, chemical and morphological parameters of old rats. Magnesium Res. 7 (1994) 233-243.
10. Domagala, J. M.: Structure-activity and structure-side-effect relationship for the quinolone antibacterials. J. Antimicrob. Chemother. 33 (1994) 685-706.
11. 1-integrins in human cartilage and their role in chondrocyte adhesion to collagen and fibronectin. Exp. Cell Res. 207 (1993) 235-244.
12. 1 integrins mediate chondrocyte interaction with type I collagen, type II collagen, and fibronectin. Exp. Cell Res. 205 (1993) 276-285.
13. Förster, C.; Kodak, K.; Shakibaei, M.; Merker, H. J.; Vormann, J.; Günther, T.; Stahlmann, R.: Integrins on joint cartilage chondrocytes and alterations by magnesium deficiency in immature rats. Arch. Toxicol. 70 (1996a) 261-270.
14. Förster, C.; Kociok, K.; Shakibaei, M.; Merker, H. J.; Stahlmann, R.: Quinolone-induced cartilage lesions are not reversible in rats. Arch. Toxicol. 70 (1996b) 474-481.
15. Förster, C.; Zippel, U.; Lozo, E.; Vormann, J.; Merker, H. J.; Stahlmann, R.: Effects of quinolones on joint cartilage in juvenile rats and other animals: focus on mechanistic aspects. Chemother. J. (1996c) 5 (Suppl. 13): 6-13.
16. Gough, A. W.; Kasali, O. B.; Sigler, R. E.; Baragi, V.: Quinolone arthropathy - acute toxicity to immature cartilage. Toxicol. Pathol. 20 (1992) 436-450.
17. 2+ in cartilage due to a Donnan distribution by chondroitin sulfate. Arch. Toxicol. (1997) (in press).
18. Günther, T.: Biochemistry and pathobiochemistry of magnesium. Mg.-Bull. 3 (1981) 91-101.
19. Günther, T.; Vormann, J.; Höllriegl, V.; Disch, G.; Classen, H.-G.: Role of lipid peroxidation and vitamin E in magnesium deficiency. Mg.-Bull. 14 (1992) 57-66.
20. Halliwell, B.; Gutteridge, J. M. C.: Role of free radicals and catalytic metal ions in human disease: An overview. Methods Enzymol. 186 (1990) 1-85.
21. Hampel, B.; Hullmann, R.; Schmidt, H.: Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use. Safety report. Pediatr. Infect. Dis. J. (1996) (in press).
22. Hayem, G.; Petit, P. X.; Levacher, M.; Gaudin, C.; Kahn, M. F.; Pocidalo, J. J.: Cytofluorometric analysis of chondrotoxicity of fluoroquinolone antimicrobial agents. Antimicrob. Agents Chemother. 38 (1994) 243-247.
23. Höffken, G. K.; Borner, K.; Glatzel, P. D.; Köppe, P.; Lode, H.: Reduced enteral absorption of ciprofloxacin in the presence of antacids. Eur. J. Clin. Microbiol. 4 (1985) 345 (letter).
24. Hunt, B. J.: Age and magnesium deficiency in the rat with emphasis on bone and muscle magnesium. Am. J. Physiol. 221 (1971) 1809-1817.
25. Ingham, B.; Brentnall, D. W.; Dale, E. A.; MacFadzean, J. A.: Arthropathy induced by antibacterial fused N-alkyl-3-pyridone-carboxylic acids. Toxicol. Let. 1 (1977) 21-26.
26. Jones, J. E.; Schwarz, R.; Krook, L.: Calcium homeostasis and bone pathology in magnesium deficient rats. Calcif. Tissue Int. 31 (1980) 231-238.
27. Kato, M.; Onodera, T.: Morphological investigation of cavity formation in articular cartilage induced by ofloxacin in rats. Fund. Appl. Toxicol. 11 (1988a) 110-119.
28. 3H]thymidine by articular cartilage cells in the rat. Toxicol. Let. 44 (1988b) 131-142.
29. Kato, M.; Takada, S.; Ogawara, S.; Takayama, S.: Effect of levofloxacin on glycosaminoglycan and DNA synthesis of cultured rabbit chondrocytes at concentrations inducing cartilage lesions in vivo. Antimicrob. Agents Chemother. 39 (1995) 1979-1983.
30. Kawai, Y.; Matsubayashi, K.; Hakusui, H.: Interaction of quinolones with metal cations in aqueous solution. Chem. Pharm. Bull. 44 (1996) 1425-1430.
31. Kociok, K.; Lozo, E.; Förster, C.; Dalsenter, P.; Kastner, U.; Vormann, J.; Stahlmann, R.: Chondrotoxicity of ofloxacin in immature rats is not detectable with a segment-III-type study. Teratology 53 (1996) 32A (abstract P33).
32. Lecomte, S.; Baron, M. H.; Chenon, M. T.; Conpry, C.; Moreau, N. J.: Effect of magnesium complexation by fluoroquinolones on their antibacterial properties. Antimicrob. Agents Chemother. 38 (1994) 2810-2816.
33. Linseman, D. A.; Hampton, L. A.; Branstetter, D. G.: Quinolone-induced arthropathy in the neonatal mouse: morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin. Fund. Appl. Toxicol. 28 (1995) 59-64.
34. Lode, H.: Drug interactions with quinolones. Rev. Infect. Dis. 10 (Suppl. 1) (1988) 132-136.
35. Loeser, R. F.: Integrin-mediated attachment of articular chondrocytes to extracellular matrix proteins. Arthritis Rheum. 36 (1993) 1103-1110.
36. Loeser, R. F.: Modulation of integrin mediated attachment of chondrocytes to extracellular matrix proteins by cations, retinoic acid and transforming growth factor β. Exp. Cell. Res. 211 (1994) 17-23.
37. Lomaestro, B. M.; Bailie, G. R.: Quinolone-cation interactions: a review. Ann. Pharmacother. 25 (1991) 1249-1258.
38. Lozo, E.; Förster, C.; Dietz, M.; Löwe, W.; Baumann, I.; Thiel, R.; Stahlmann, R.: Ciprofloxacin and N-methyl-ciprofloxacin induce joint cartilage lesions in immature rats. Teratology 53 (1996) 32A (abstract P34).
39. Machida, M.; Kusajima, H.; Aijima, H.; Maeda, A.; Ishida, R.; Uchida, H.: Toxicokinetic study of norfloxacin-induced arthropathy in juvenile animals. Toxicol. Appl. Pharmacol. 105 (1990) 403-412.
40. Macallum, E.; Houston, B.; Smith, G.: Subchronic toxicity of a quinolone antibacterial agent in Beagle dogs. Toxicologist 13 (1993) 377 (abstract 1473).
41. Marshall, A. J. H.; Piddock, L. J. V.: Effect of cations and EDTA upon the activity of 18 quinolones, gentamicin, ceftazidime and polymixin against gram-negative and gram-positive bacteria. Drugs 45 (Suppl. 3) (1993) 150-151.
42. Mayer, D. G.: Overview of toxicological studies. Drugs 34 (Suppl. 1) (1987) 150-153.
43. Meissner, A.; Borner, K.; Koeppe, P.: Concentrations of ofloxacin in human bone and cartilage. J. Antimicrob. Chemother. 26 (Suppl. D) (1990) 69-74.
44. Milazzo, S. C.: Ahern, M. J.: Cleland, L. G.; Henderson, D. R. F.: Calcium pyrophosphate dihydrate deposition disease and familial hypomagnesemia. J. Rheumatol. 8 (1981) 767-771.
45. Munoz-Fernandez, S.; Pantoja, L.; Mola, E. M.; de Miguel, E.; Banos, J. G.: Chondrocalcinosis associated with Bartter's syndrome and hypomagnesemia. J. Rheumatol. 21 (1994) 9-10.
46. N. N.: Sparfloxacin Monograph. Rhone-Poulenc Rorer ADIS Press, (1994) p. 18.
47. Nakamura, M.; Abe, S.; Goto, Y.; Chishaki, A.; Akazawa, K.; Kato, M.: In vivo assessment of prevention of white-noise-induced seizure in magnesium-deficient rats by N-methyl-D-aspartate receptor blockers. Epilepsy Res. 17 (1994) 249-256.
48. Palu, G.; Valisena, S.; Ciarrochi, G.; Gatto, B.; Palumbo, M.: Quinolone binding to DNA is mediated by magnesium ions. Proc. Natl. Acad. Sci. USA 89 (1992) 9671-9675.
49. Rayssiguier, Y.; Gueux, E.; Bussiere, L.; Durlach, J.; Mazur, A.: Dietary magnesium affects susceptibility of lipoproteins and tissues to peroxidation in rats. J. Am. Coll. Nutrit. 12 (1993) 133-137.
50. Ross, D.; Riley, R.: Physicochemical properties of the fluoroquinolone antimicrobials. V. Effect of fluoroquinolone structure and pH on the complexation of various fluoroquinolones with magnesium and calcium ions. Int. J. Pharm. 93 (1993) 121-129.
51. Schwabe, R.; Zippel, U.; Förster, C.; Baumann-Wilschke, I.; Stahlmann, R.: Plasma concentrations and chondrotoxicity of three fluoroquinolones in juvenile rats. Naunyn Schmiedeberg's Arch. Pharmacol. 354 (Suppl. 1) (1996) abstract 110.
52. Shakibaei, M.; Kociok, K.; Förster, C.; Vormann, J.; Günther, T.; Stahlmann, R.; Merker, H. J.: Comparative evaluation of ultrastructural changes in articular cartilage of juvenile rats after treatment with ofloxacin and in magnesium-deficient rats. Toxicol. Pathol. 24 (1996) 580-587.
53. Smilde, T. J.; Haverman, J. F.; Schipper, P.; Hermus, A. R. M. M.; van Liebergen, F. J. H. M.; Jansen, J. L. J.; Kloppenborg, P. W. C.; Koolen, M. I.: Familial hypokalemia/hypomagnesemia and chondrocalcinosis. J. Rheumatol. 21 (1994) 1515-1519.
54. Stahlmann, R.; Förster, C.; Shakibaei, M.; Vormann, J.; Günther, T.; Merker, H. J.: Magnesium deficiency induces joint cartilage lesions in juvenile rats which are identical with quinolone-induced arthropathy. Antimicrob. Agents. Chemother. 39 (1995) 2013-2018.
55. Stahlmann, R.; Förster, C.; Van Sickle, D.: Quinolones in children: are concerns over arthropathy justified? Drug Safety 9 (1993) 397-403.
56. Stahlmann, R.; Merker, H. J.; Hinz, N.; Webb, J.; Heger, W.; Neubert, D.: Ofloxacin in juvenile non-human primates and rats. Arthropathia and drug plasma concentrations. Arch. Toxicol. 64 (1990) 193-204.
57. Stahlmann, R.; Zippel, U.; Förster, C.; Borner, K.: Concentrations of sparfloxacin in plasma, cartilage and bone of immature rats at chondrotoxic and non-chondrotoxic doses. Naunyn Schmiedeberg's Arch. Pharmacol. 354 (Suppl. 1) (1996) abstract 97.
58. Syllm-Rapoport, I.; Strassburger, I.; Grüneberg, D; Zirbel, C.: Über den experimentellen Magnesium-Mangel beim Hund. Acta Biol. Med. Germ. 1 (1958) 141-163.
59. Takayama, S.; Hirohashi, M.; Kato, M.; Shimada, H.: Toxicity of quinolone antimicrobial agents. J. Toxicol. Env. Health 45 (1995) 1-45.
60. Tatsumi, H.; Senda, H.; Yatera, S.; Takemoto, Y.; Yamayoshi, Ohnishi, K.: Toxicological studies on pipemidic acid V. Effect on diarthrodial joints of experimental animals. J. Toxicol. Sci. 3 (1978) 357-367.
61. Vormann, J.; Günther, T.: Development of fetal mineral and trace element metabolism in rats with normal as well as magnesium- and zinc-deficient diets. Biol. Trace. Elem. Res. 9 (1986) 37-59.
62. Vormann, J.; Günther, T.: The role of magnesium and zinc in determining vulnerability of the auditory system to salicylate and gentamicin. Arch. Compl. Env. Stud. 3 (1991) 75-82.
63. Vormann, J.; Günther, T.; Höllriegl, V.; Schümann, K.: Effects of various degrees and duration of magnesium deficiency on lipid peroxidation and mineral metabolism in rats. J. Nutr. Biochem. 6 (1995) 681-688.
64. Vormann, J.; Förster, C.; Zippel, U.; Lozo, E.; Günther, T.; Merker, H. J.; Stahlmann, R.: Effects of magnesium deficiency on magnesium and calcium content in bone and cartilage in developing rats in correlation to chondrotoxicity. Calc. Tiss. Intern. (1997) (in press).
65. Weglicki, W. B.; Mak, I. T.; Stafford, R. E.; Dickens, B. F.; Cassidy, M. M.; Phillips, T. M.: Neurogenic peptides and the cardiomyopathy of magnesium deficiency: effects of substance P-receptor inhibition. Mol. Cell. Biochem. 130 (1994) 103-109.
66. Weglicki, W. B.; Phillips, T. M.; Freedman, A. M.; Cassidy, M. M.; Dickens, B. F.: Magnesium deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol. Cell. Biochem. 110 (1992) 169-173.
67. Williams, P. D.; Helton, D. R.: The proconvulsive activity of quinolone antibiotics in an animal model. Toxicol. Lett. 58 (1991) 23-28.